VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt

NCT00299325 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Syndrome

Interventions

DRUG: Rimonabant
DRUG: Placebo (for Rimonabant)
OTHER: Mild hypocaloric diet

Sponsor

Sanofi